The Federal Trade Commission and U.S. Justice Department’s proposed merger guidelines could slow the rapid pace of acquisitions and consolidations in the health care industry, antitrust lawyers said this week.  

The draft guidelines, released in July, are designed to ensure acquisitions do not harm competition in the market, reflecting the Biden administration’s stated goal of aggressive oversight of planned corporate mergers. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]